These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6987)

  • 1. Withdrawal causes relapse? Our response.
    MacDonald ML; Tobias LL
    Psychol Bull; 1976 May; 83(3):448-51. PubMed ID: 6987
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
    Davis JM; Gosenfeld L; Tsai CC
    Psychol Bull; 1976 May; 83(3):431-47. PubMed ID: 6986
    [No Abstract]   [Full Text] [Related]  

  • 3. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychotic recurrence after antipsychotic discontinuation.
    Zipursky RB
    Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychopharmacol; 2008 Aug; 28(4):401-5. PubMed ID: 18626266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phenothiazines on anxiety and cognition in schizophrenia.
    Meadow A; Donlon PT; Blacker KH
    Dis Nerv Syst; 1975 Apr; 36(4):203-8. PubMed ID: 234827
    [No Abstract]   [Full Text] [Related]  

  • 8. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 9. The early course of schizophrenia and long-term maintenance neuroleptic therapy.
    Nuechterlein KH; Gitlin MJ; Subotnik KL
    Arch Gen Psychiatry; 1995 Mar; 52(3):203-5. PubMed ID: 7872846
    [No Abstract]   [Full Text] [Related]  

  • 10. False-positive dexamethasone suppression test results related to antipsychotic drug withdrawal: case report.
    Devanand DP; Pandurangi AK; Dewan MJ
    J Clin Psychiatry; 1984 Jun; 45(6):275-6. PubMed ID: 6144673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment for lifetime disorders?
    Greden JF; Tandon R
    Arch Gen Psychiatry; 1995 Mar; 52(3):197-200. PubMed ID: 7872844
    [No Abstract]   [Full Text] [Related]  

  • 12. Stopping drug treatment in schizophrenia.
    Drug Ther Bull; 1987 Apr; 25(8):31-2. PubMed ID: 2884089
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing treatment of schizophrenia to minimize relapse.
    Samalin L; Blanc O; Llorca PM
    Expert Rev Neurother; 2010 Feb; 10(2):147-50. PubMed ID: 20136373
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychopharmacology in the secondary and tertiary prevention of mental illness.
    Ban TA
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():403-8. PubMed ID: 45168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of relapse in schizophrenia.
    Lieberman J; Stroup S; Schneider L
    N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11987324
    [No Abstract]   [Full Text] [Related]  

  • 17. [Discontinuation of neuroleptic treatment in patients with schizophrenia].
    Alagille M; Blondiaux I; Ginestet D
    Encephale; 1990; 16(2):125-31. PubMed ID: 1972052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.
    Poyurovsky M; Bergman Y; Shoshani D; Schneidman M; Weizman A
    Clin Neuropharmacol; 1998; 21(2):97-100. PubMed ID: 9579295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.